Cardiovascular risk assessment tools in Asia
3
Issued Date
2022-04-01
Resource Type
ISSN
15246175
eISSN
17517176
Scopus ID
2-s2.0-85122190080
Pubmed ID
34981620
Journal Title
Journal of Clinical Hypertension
Volume
24
Issue
4
Start Page
369
End Page
377
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Clinical Hypertension Vol.24 No.4 (2022) , 369-377
Suggested Citation
Zhang Y. Cardiovascular risk assessment tools in Asia. Journal of Clinical Hypertension Vol.24 No.4 (2022) , 369-377. 377. doi:10.1111/jch.14336 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/86010
Title
Cardiovascular risk assessment tools in Asia
Author(s)
Author's Affiliation
Hiroshima City Asa Citizens Hospital
Siriraj Hospital
University Medicine and Pharmacy, Hue University
Sunway University
Hanyang University Medical Center
Jichi Medical University
Yonsei University Health System
Shanghai Jiao Tong University School of Medicine
Madras Institute of Orthopaedics and Traumatology Hospitals
National Taiwan University Hospital
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
Faculty of Medicine, Chiang Mai University
Department of Medicine
Universiti Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
King George's Medical University
Veterans General Hospital-Taipei
Chinese University of Hong Kong
Tan Tock Seng Hospital
Medical Center Manila
Punjab Medical Center
Siriraj Hospital
University Medicine and Pharmacy, Hue University
Sunway University
Hanyang University Medical Center
Jichi Medical University
Yonsei University Health System
Shanghai Jiao Tong University School of Medicine
Madras Institute of Orthopaedics and Traumatology Hospitals
National Taiwan University Hospital
Kathmandu University
University of the East Ramon Magsaysay Memorial Medical Center
National Yang-Ming University Taiwan
Universitas Katolik Indonesia Atma Jaya
Universitas Indonesia
Faculty of Medicine, Chiang Mai University
Department of Medicine
Universiti Malaya
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
King George's Medical University
Veterans General Hospital-Taipei
Chinese University of Hong Kong
Tan Tock Seng Hospital
Medical Center Manila
Punjab Medical Center
Other Contributor(s)
Abstract
Cardiovascular disease (CVD) is becoming the most important burden to health care systems in most part of the world, especially in Asia. Aiming at identifying high risk individuals and tailoring preventive treatment, many cardiovascular risk assessment tools have been established and most of them were developed in Western countries. However, these cardiovascular risk assessment tools cannot be used interchangeably without recalibration because of the different risk factor profiles (ie, greater absolute burden of hypertension and lower level of total-cholesterol in Asians and higher prevalence of metabolic disorders in South Asians) and different CVD profiles (higher ratio of stroke/coronary heart disease in Asians) between Western and Asian populations. Original risk models such as Prediction for ASCVD Risk in China (China-PAR) and Japan Arteriosclerosis Longitudinal Study (JALS) score have been developed and well validated for specific countries, while most of countries/regions in Asia are using established models. Due to higher incidence of stroke in Asians, risk factors like hypertension should weigh more in cardiovascular risk assessment comparing with Western populations, but their actual proportions should be based on CVD profiles in specific countries/regions. The authors encourage the development of new cardiovascular risk assessment tools for Asians, if possible. Still, modifying established models with native epidemiological data of risk factor as well as CVD is acceptable in regions where health care resources are insufficient.